INS and diabetes mellitus: This consortium aims to address the need for reliable clinical-quality assays to enhance the reproducibility of diabetes clinical research through the development of robust, transferable, harmonizable targeted MS assays for the quantification of proteins and peptides of interest (eg, C-peptide, insulin, glucagon) to the diabetes translational research community.